Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
05 May 2015
IN THIS ISSUE
News
Webcasts
Events
About Us
Featured Content
More Evidence that Size Matters
Big service providers get bigger faster thanks to Big Pharma. More...
 
The Human Microbiome Project and Pharmaceutical Quality Control Microbiology
The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology. More...
 
The Role of Regulatory Advice in Drug Development
Drug developers understand the importance of early communication with regulators, but is EMA providing enough flexibility and support to companies? More...
 
Top Stories
The Acquisition Battle Continues with Another Perrigo Rejection
Ireland-based Perrigo rejects Mylan's second proposal for an acquisition valued at more than $34 billion, saying that the offer was too low to consider. More...
 
Takeda Faces Cancer Lawsuits with $2.4 Billion in Settlements
Takeda Pharmaceutical agrees to pay $2.4 billion to settle lawsuits from patients and family members who said the diabetes drug Actos caused bladder cancer. More...
 
Industry News
Mylan Rejects Teva's $40 Billion Offer
In a smoldering letter, Mylan's executive chairman announced the unanimous rejection of a $40-billion unsolicited acquisition offer from Teva. More...
 
FDA Releases Final Biosimilar Guidance
FDA releases long-awaited guidance documents regarding the assessment of biosimilarity. More...
 
Innate Pharma Announces $1.3 Billion Collaboration with AstraZeneca
Innate Pharma announces a co-development and commercialization agreement with AstraZeneca to accelerate the development of Innate’s anti-NKG2A antibody. More...
 
Breaking Down Pharma Borders
With the Indian pharmaceutical industry on the rise, manufacturing businesses are working together with European and American partners to harness their longstanding experience and reputation in cleanroom manufacturing for a broader pharmaceutical manufacturing marketplace. More...
 
Mylan Recalls Injectables Due to Visible Particulate Matter
Mylan announces a recall of eight lots of injectable products due to visible foreign particulate matter. More...
 
Webcasts
Practical Guidance for Successful Mammalian Cell Banking & Cell Line Characterization
Thursday, May 14, 2015, 11 am EDT/8 am PDT/16:00 BST/17:00 CEST
Sponsored by Eurofins Lancaster Laboratories
 
Stability Assessment for Shipment of API and Drug Products
Thursday, May 21, 2015, 11 am EDT
Sponsored by Patheon
 
More Webcasts

Product/Service Profiles
Adare Pharmaceuticals, Inc.

Aptalis Pharmaceutical Technologies is now
Adare Pharmaceuticals

On April 1, 2015, Aptalis Pharmaceutical Technologies was divested from Actavis plc (NYSE: ACT) to TPG, a global private investment firm. The company’s new name is Adare Pharmaceuticals.
Read more
Albany Molecular Research Inc.

AMRI Glasgow Ltd. is located in the United Kingdom. The site provides pre-formulation, formulation and process development services, as well as manufacture of sterile products for clinical trials.
Read more
LB Bohle

Bohle Uni Cone BUC ®
With the innovative and patented Bohle Uni Cone BUC® process a complete fluidization is assured which leads to a high coating uniformities and high yields in the final product.
Read more
Shimadzu

The Swiss Knife of analytics
Shimadzu has released its new Nexera UC unified chromatography system. It is the world’s first-ever unified and fully automated instrument combining supercritical fluid extraction (SFE) with supercritical fluid chromatography (SFC).
Read more
TSI Incorporated

BIOTRAK™ REAL-TIME VIABLE PARTICLE COUNTER FOR IMPROVED ROOT CAUSE INVESTIGATIONS
Benefits of a real-time viable result include, immediate initiation of root cause investigations, faster detection of adverse trends, risk based room release, and fewer interventions into RABS and Isolators to change agar plates
Read more

Event Profile
CPhI Istanbul 2015 - The Leading Pharma Event in Eurasia

Date: 3rd - 5th June 2015
Venue: Istanbul Congress Center, ICC
CPhI Istanbul and co-located events P-MEC, InnoPack and ICSE will bring together local Turkish and regional (the Balkans, Central Asia, Middle East and North Africa) drug manufacturers with global suppliers of raw materials, machinery, packaging solutions and contract services (4 events under 1 roof).
Read more
 

Reference Library

Pharmaceutical Technology Drug Delivery Guides
A three-volume set of drug delivery system handbooks. A compilation of articles related to methods and processes of manufacturing and administering pharmaceutical compounds to achieve therapeutic effects.  Topics include the development of controlled-release formulations and reformulating injectable drugs for oral delivery. ... Click here

Contact Us

Click here to contact editorial.

Click here to contact sales.